Skip to main content
. Author manuscript; available in PMC: 2018 Apr 23.
Published in final edited form as: Cancer Res. 2010 Apr 13;70(9):3586–3593. doi: 10.1158/0008-5472.CAN-09-3197

Table 2.

Incidence of CIN-III and ICC according to the number of gynecologic examinations during follow-up (VHM&PP, 1985–2003)

Outcome No. of gynecologic examinations P trend*

0
(n = 19,489)
1–2
(n = 19,023)
3–5
(n = 20,433)
≥6
(n = 33,898)
Positive cytology (class III, IV, V), no. (%)* n.a. 281 (1.5) 579 (2.8) 1,662 (4.9) <0.0001
CIN-III, no. (%) n.a. 243 (1.3) 266 (1.3) 193 (0.6) <0.0001
ICC, no. (%) 39 (0.2) 47 (0.2) 22 (0.1) 9 (0.0) <0.0001
*

Papanicolaou classification system.

Screening detected.